A Hangover Under 177 Lu-PSMA-617 Therapy : A Red Flag for Brain 68 Ga-PSMA-11 PET/MRI?
In: Clinical nuclear medicine, Jg. 49 (2024-06-01), Heft 6, S. 582-583
academicJournal
Zugriff:
Abstract: Leptomeningeal carcinomatosis in prostate cancer is extremely rare. Because of the low overall penetration of drugs into the brain and the prolonged survival of castration-resistant prostate cancer (CRPC) patients, a special attention should be paid to the appearance of neurological symptoms in long-term CRPC survivors. A patient suffering from a CRPC with bone metastases underwent 4 cycles of 177 Lu-PSMA (prostate-specific membrane antigen)-617. Starting from the third cycle, he reported an increasing feeling of a permanent hangover. A 68 Ga-PSMA-11 brain PET/MRI was carried out after the fourth cycle. It revealed intraparenchymatous brain metastases with intense uptake and evidences of leptomeningeal carcinomatosis.
Competing Interests: Conflicts of interest and sources of funding: none declared.
(Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
Titel: |
A Hangover Under 177 Lu-PSMA-617 Therapy : A Red Flag for Brain 68 Ga-PSMA-11 PET/MRI?
|
---|---|
Autor/in / Beteiligte Person: | Poterszman, N ; Somme, L ; Bund, C ; Hutt, E ; Somme, F |
Zeitschrift: | Clinical nuclear medicine, Jg. 49 (2024-06-01), Heft 6, S. 582-583 |
Veröffentlichung: | Philadelphia, Lippincott., 2024 |
Medientyp: | academicJournal |
ISSN: | 1536-0229 (electronic) |
DOI: | 10.1097/RLU.0000000000005126 |
Schlagwort: |
|
Sonstiges: |
|